New research indicates a wireless device could do a better job than the Holter monitor, the standard of care for mobile heart rhythm monitoring over the past half-century. The Scripps Translational ...
The wearable cardiac monitor maker VitalConnect has raised $100 million in new capital to aid in the development of its in-hospital wireless patient trackers while also expanding its commercial ...
A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...
Ambulatory patch device designed to aid in detecting ischemia and complex arrythmias Targets a $2 billion market with established reimbursement; ischemia detection has potential to disrupt the patch ...
A lightweight wearable device developed by UNSW engineers could one day help people monitor their heart and breathing health from home, potentially reducing hospital visits and allowing doctors to ...
NASDAQ:MDGL: $1.2 billion (11.6% of AUM) NASDAQ:INSM: $842.9 million (8.4% of AUM) NASDAQ:PTCT: $588.4 million (5.9% of AUM) NASDAQ:ARGX: $566.4 million (5.7% of AUM) NASDAQ:PTGX: $441.9 million (4.4% ...
Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results